Standard InChI: InChI=1S/C12H19N5O2S/c1-20-5-9(19)8(4-18)14-2-7-3-15-11-10(7)16-6-17-12(11)13/h3,6,8-9,14-15,18-19H,2,4-5H2,1H3,(H2,13,16,17)/t8-,9-/m0/s1
1.Clinch K, Evans GB, Fröhlich RF, Gulab SA, Gutierrez JA, Mason JM, Schramm VL, Tyler PC, Woolhouse AD.. (2012) Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics., 20 (17):[PMID:22854195][10.1016/j.bmc.2012.07.006]
2.Longshaw, Alistair I and 5 more authors. 2010-09-23 Design and synthesis of potent "sulfur-free" transition state analogue inhibitors of 5'-methylthioadenosine nucleosidase and 5'-methylthioadenosine phosphorylase. [PMID:20718423]
3.Clinch, Keith and 8 more authors. 2012-09-01 Transition state analogue inhibitors of human methylthioadenosine phosphorylase and bacterial methylthioadenosine/S-adenosylhomocysteine nucleosidase incorporating acyclic ribooxacarbenium ion mimics. [PMID:22854195]
4.Evans, Gary B and 7 more authors. 2015-09-01 Tight binding enantiomers of pre-clinical drug candidates. [PMID:26260335]
5.Harijan, Rajesh K and 7 more authors. 2019-04-11 Selective Inhibitors of Helicobacter pylori Methylthioadenosine Nucleosidase and Human Methylthioadenosine Phosphorylase. [PMID:30860833]